GlassScriptPhysician profile
Thomas J Forest
NPI 1760489637
$809.41
in general payments reported to CMS, 2019-2025
12 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.06 · 2020: $47.99 · 2021: $147 · 2022: $54.74 · 2023: $103 · 2024: $120 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $71.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $71.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $174.35 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $164.95 | 2019-2023 | |
| C. R. Bard, INC. & Subsidiaries | $124.38 | 2025 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $97.65 | 2023-2024 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $59.83 | 2021-2023 | Pylarify |
| Zyla Life Sciences, INC. | $51.62 | 2019-2020 | |
| Novo Nordisk INC | $29.07 | 2024 | Rivfloza |
| Alnylam Pharmaceuticals INC. | $27.91 | 2021 | |
| Procept Biorobotics Corporation | $25.34 | 2023 | Aquabeam Robotic System |
| Antares Pharma, INC. | $20.21 | 2020 | |
| Hollister Incorporated | $17.64 | 2022 | |
| Endo Pharmaceuticals INC. | $16.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Forest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.